Charlton, Bruce G <br/><br/>
If 'atypical' neuroleptics did not exist, it wouldn't be necessary to invent them: perverse incentives in drug development, research, marketing and clinical practice.  [electronic resource] 

 -  Medical hypotheses  2005 
 - 1005-9 p.  digital 
<br/><br/> Publication Type: Editorial 
<br/><br/><label>ISSN: </label>0306-9877 
<br/><br/><label>Standard No.: </label>10.1016/j.mehy.2005.08.013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antipsychotic Agents--adverse effects<br/>Drug Design<br/>Drug Industry--ethics<br/>Ethics, Business<br/>Ethics, Clinical<br/>Ethics, Research<br/>Humans<br/>Marketing--ethics<br/>Practice Patterns, Physicians'--ethics<br/>Psychotic Disorders--drug therapy